TransCure at Advances in Immuno-Oncology

Event's date
From : 8 October 2019
to : 9 October 2019
Event's place
San Diego, USA

TransCure will be attending the 2nd Annual Advances in Immuno-Oncology USA Congress

Our CEO, Patrick NEF, will be in San Diego. during the 2nd Annual Advances in Immuno-Oncology, October 8th to 9th. Meet him there to talk about fully humanized immune system mouse models for immunity-targeted preclinical assessment.

Click here to pre-arrange a face-to-face :

Who are we?

TransCure is the only CRO specialized in fully humanized immune system mouse models (hu-mice). We have developed a strong expertise through data driven approaches for the complete & functional reconstitution of a human immune system in severely immunodeficient mouse strains (NOG, BRG, BRG-S, NCG). With this platform, we provide human disease models for drug efficacy & safety assessment in cancer / immuno-oncology, inflammation / auto-immunity, infectious diseases and liver diseases. The hu-mouse is also used to produce 100% human IGs and cytokines.

Share this!